Literature DB >> 9294792

Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?

M A Scheiner, S E Kimmel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9294792      PMCID： PMC1497168          DOI： 10.1046/j.1525-1497.1997.07147.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  9 in total

1.  Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.

Authors:  M H Chin; J C Wang; J X Zhang; R M Lang
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

2.  Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.

Authors:  M H Chin; P D Friedmann; C K Cassel; R M Lang
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

Review 4.  Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

6.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

7.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

8.  Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators.

Authors:  M G Bourassa; O Gurné; S I Bangdiwala; J K Ghali; J B Young; M Rousseau; D E Johnstone; S Yusuf
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

Review 9.  Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  J B Young; D H Weiner; S Yusuf; C M Pratt; J B Kostis; M B Weiss; E Schroeder; M Guillote
Journal:  South Med J       Date:  1995-05       Impact factor: 0.954
  9 in total
  1 in total

1.  Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis.

Authors:  Diane M Richardson; Kevin T Bain; James J Diamond; Karen D Novielli; Seina P Lee; Neil I Goldfarb
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 4.271
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.